Laboratory tests in primary care · by Dr Solange Déplanque and Dr Michaël Rochoy

Hypertension in pregnancy (gestational hypertension, suspected pre-eclampsia, chronic hypertension)

Gynaecology and obstetrics · Symptom or situation · updated 2026-10-30

BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.

Frequency: 5 to 10% of pregnancies [1]

Severe hypertension or severity sign: emergency

Detailed explanation and international comparison (in French): read it in English (machine translation)

Hypertension found after 20 weeks of gestation, without severity signs

Urine tests on a spot sample (not necessarily first morning)

Laboratory tests

Then every week as long as the gestational hypertension lasts

Detailed explanation and international comparison (in French): read it in English (machine translation)

Do not order

Chronic hypertension (known before pregnancy or before 20 weeks of gestation)

Urine tests (dipstick every month; laboratory if ≥ 1+)

Laboratory tests in early pregnancy

Detailed explanation and international comparison (in French): read it in English (machine translation)

Also consider

After delivery

Fasting sample.

48 to 72 hours after delivery (pre-eclampsia; often done at the maternity unit)

Visit 6 to 8 weeks after delivery

At 3 months if proteinuria persists (≥ 1+)

Every year for the first 5 years

Detailed explanation and international comparison (in French): read it in English (machine translation)

Do not order

Sources (11)
  1. Société française d'hypertension artérielle (SFHTA), en partenariat avec le CNGOF. HTA et grossesse. Consensus d'experts, décembre 2015. Publié : Mounier-Vehier C, Amar J, Boivin JM, et al. Presse Med. 2016;45(7-8 Pt 1):682-99.
  2. Société française d’anesthésie et de réanimation (SFAR), Collège national des gynécologues et obstétriciens français (CNGOF). Prise en charge de la patiente avec une pré-éclampsie sévère. Recommandations formalisées d’experts communes, 2020 (version publiée : Bonnet MP et al. Anaesth Crit Care Pain Med. 2021;40(5):100901).
  3. National Institute for Health and Care Excellence (NICE). Hypertension in pregnancy: diagnosis and management. NICE guideline NG133, juin 2019, dernière mise à jour 17 avril 2023.
  4. Society of Obstetric Medicine of Australia and New Zealand (SOMANZ). Hypertension in Pregnancy Guideline 2023.
  5. Sentilhes L, Schmitz T, Arthuis C, et al. La prééclampsie : recommandations pour la pratique clinique du Collège national des gynécologues et obstétriciens français (CNGOF). Gynecol Obstet Fertil Senol. 2024;52(1):3-44.
  6. Agence du numérique en santé. Terminologie LAHN (liste des actes innovants hors nomenclature de biologie et d'anatomopathologie), version 2026-04 : code K301 (Placental Growth Factor).
  7. Magee LA, Brown MA, Hall DR, et al. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2022;27:148-169.
  8. US Preventive Services Task Force, Barry MJ, et al. Screening for Hypertensive Disorders of Pregnancy: US Preventive Services Task Force Final Recommendation Statement. JAMA. 2023;330(11):1074-1082.
  9. Nederlandse Vereniging voor Obstetrie en Gynaecologie (NVOG). Richtlijn Hypertensieve aandoeningen in de zwangerschap, module « Afkapwaarde EKR - pre-eclampsie », 14 juin 2021 (Pays-Bas).
  10. Lala V, Franzese S. Role of sFlt-1/PlGF Ratio in Diagnosing Preeclampsia. Am Fam Physician. 2024;109(5):470-471.
  11. Nederlandse Vereniging voor Obstetrie en Gynaecologie (NVOG) et al. Richtlijn CVRM na een reproductieve aandoening, module « Organisatie van zorg bij HAZ », 2 mars 2023 (Pays-Bas).